| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_053bc759c9760bbade33e372a9d1f66b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99c89ff9d3dca71f4d0b7eab1827e4f5 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 |
| filingDate |
1997-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d374393ade98345bdb55b896d1e86f2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29d611d42c95d13991a042930b250813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1817995512a06a46bfdce0d7be8fd616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b273123de5a376844064ceaf13f2ad5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1210a306f9e7e8871df87a615251e7af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6f5fb4d08d6b1ed1e5d6656737bac9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb29cdfce29babe8637a88ac3a4c964c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84049b6b4ece9f6209a1202c8657a484 |
| publicationDate |
1999-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2128987-C1 |
| titleOfInvention |
Rectal suppositories for treatment of pediatric patients |
| abstract |
FIELD: medicine, pharmacy. SUBSTANCE: invention relates to suppositories exhibiting vasodilating and spasmolytic effects. Suppositories have dibazol - 0.002 g per a single suppository (mass is 1.15-1.40 g). Base is solid candy fat of type A on the basis of plasticized hydrogenated fat or vitepsol - a mixture of triglycerides, diglycerides and monoglycerides of C 12 -C 18 -fatty acids. The use of suppositories excludes irritating effect on rectum intestine mucosa in children. Suppositories can be recommended for children with nausea and vomiting especially. Suppositories do not show adverse responses in baby organism. EFFECT: enhanced effectiveness of treatment. 1 tbl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2001288039-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1319397-A4 |
| priorityDate |
1997-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |